In This Section

Program

Sunday, February 28, 2021

Monday, March 1, 2021

Tuesday, March 2, 2021

Wednesday, March 3, 2021

Sunday, February 28, 2021

Welcome and Keynote Lectures
5-6:15 p.m.

Welcome

Keynote Lecture
Title to be announced
Robert G. Bristow, University of Manchester, Manchester, United Kingdom

Opening Reception
6:20-8 p.m.

Monday, March 1, 2021

Continental Breakfast
7:30-8:30 a.m.
Plenary Session 1: Hypoxia
8:30-10:30 a.m.

Title to be announced
Ester M. Hammond, University of Oxford, Oxford, United Kingdom

Targeting redox homeostasis to improve radiation response of pancreatic cancer                                                               
Marianne Koritzinsky, Princess Margaret Cancer Centre, Toronto, ON, Canada

Oxygen sensing in the context of chromatin
Sonia Rocha, University of Liverpool, Liverpool, United Kingdom

Hypoxia shapes tumor evolutionary landscapes
Paul Boutros, University of California Los Angeles, Los Angeles, California

Break
10:30-10:45 a.m.
Plenary Session 2: Microenvironment
Session Chair: Mary Helen Barcellos-Hoff, University of California San Francisco, San Francisco, California
10:45 a.m.-12:15 p.m.

Title to be announced
Philip J. Tofilon, National Cancer Institute, Bethesda, Maryland

Title to be announced
Amato Giaccia, University of Oxford, Oxford, United Kingdom

Title to be announced
Andrea Facciabene, University of Pennsylvania, Philadelphia, Pennsylvania

Spotlight on Proffered Papers I
12:15-12:45 p.m.
Lunch (Provided)
12:45-1:45 p.m.
Poster Session A
1:30-3:30 p.m.
Plenary Session 3: Sirtuins, Cell Homeostasis, and Metabolism
3:30-5:30 p.m.

Title to be announced
David Gius, Northwestern University Chicago, Illinois

The role of sirtuins in radiation-induced cardiac dysfunction
Carmen R. Bergom, Medical College of Wisconsin, Milwaukee, Wisconsin

Sirt2: A tumor suppressor or promoter?
Fen Xia, University of Arkansas for Medical Sciences, Little Rock, Arkansas

Exploiting redox biology and metabolism for improving cancer therapy
Douglas R. Spitz, University of Iowa, Iowa City, Iowa

Evening Off / Dinner on Own
5:30 p.m.-

Tuesday, March 2, 2021

Continental Breakfast
7:30-8:30 a.m.
Plenary Session 4: Exploiting the DNA Damage Response
8:30-10:30 a.m.

Effects of targeting the DNA damage response on chromosomal break repair outcomes
Jeremy Stark, City of Hope, Duarte, California

Title to be announced
Mary Helen Barcellos-Hoff, University of California San Francisco, San Francisco, California

Title to be announced
Dipanjan Chowdhury, Dana-Farber Cancer Institute, Boston, Massachusetts

Title to be announced
Ricky Sharma, Varian, Palo Alto, California

Spotlight on Proffered Papers II
10:30-11 a.m.
Break
11-11:15 a.m.
Plenary Session 5: Exploiting the DNA Damage Response II
11:15 a.m.-12:45 p.m.

Genetic variants of base excision repair and cancer
Joann B. Sweasy, University of Arizona Cancer Center, Tucson, Arizona

Maximizing clinical benefit by strategic combinations of radiation therapy, PARP inhibitors, and other agents
Anthony J. Chalmers, University of Glasgow, Glasgow, United Kingdom

Title to be announced
Conchita Vens, Netherlands Cancer Institute, Amsterdam, Netherlands

Lunch (on Own)
12:45-2:30 p.m.
Plenary Session 6: Limiting Late Effects – Physics, Biology, and Genetics
2:30-4 p.m.

Title to be announced
Constantinos Koumenis, University of Pennsylvania, Philadelphia, Pennsylvania

Influence of the microenvironment on stem cell function and late radiation response
Rob Coppes, University Medical Center Groningen, Groningen, Netherlands

Radiogenomics to predict risk of late effects
Catharine West, University of Manchester, Manchester, United Kingdom

Spotlight on Proffered Papers III
4-4:30 p.m.
Poster Session B / Reception
4:30-6:30 p.m.

Wednesday, March 3, 2021

Continental Breakfast
7:30-8:30 a.m.
Plenary Session 7: Molecular Predictions
8:30-10 a.m.

Replication gaps underlie chemotherapy response
Sharon Cantor, University of Massachusetts Medical School, Worcester, Massachusetts

Title to be announced
Fei-Fei Liu, Princess Margaret Cancer Center, Toronto, ON, Canada

Interaction of radiotherapy and immunotherapy maybe not what you think
Ralph Weichselbaum, University of Chicago, Chicago, Illinois

Spotlight on Proffered Papers IV
10-10:30 a.m.
Break
10:30-10:45 a.m.
Plenary Session 8: Immunotherapy
10:45 a.m.-12:15 p.m.

Title to be announced
Charles G. Drake, Columbia University Medical Center, New York, New York

Integrating radiation therapy with immunotherapy
Marka R. Crittenden, Earle A. Chiles Research Institute, Portland, Oregon

Title to be announced
Silvia C. Formenti, Weill Cornell Medical College, New York, New York

Closing Remarks and Departure
12:15 p.m.